Herpes zoster reactivation after mRNA and adenovirus-vectored coronavirus disease 2019 vaccination: Analysis of National Health Insurance Database.

Jin Gu YoonYoung-Eun KimMin Joo ChoiWon Suk ChoiYu Bin SeoJaehun JungHak-Jun HyunHye SeongEliel NhamJi Yun NohJoon Young SongWoo Joo KimDong Wook KimHee Jin Cheong

Published in: The Journal of infectious diseases (2023)

mRNA COVID-19 vaccination possibly increases the risk of herpes zoster reactivation, and thus close follow-up for herpes zoster reactivation is required.

Keyphrases

coronavirus disease
health insurance
affordable care act
respiratory syndrome coronavirus
sars cov
binding protein
quality improvement
healthcare
emergency department
adverse drug
electronic health record